-
A virus based vaccine combined with IL12 gene therapy eradicates aggressive melanoma [Elektronski vir]Brišar, Nuša ...Our study introduces a novel bacteriophage-based vaccine strategy and evaluates its antitumor efficacy, both as a standalone therapy and in combination with gene electrotransfer (GET) of ... interleukin-12 (IL-12) plasmids. Using phage display technology, we produced engineered M13 bacteriophages expressing tumour peptides MAGE-A1, gp100, or MART-1/MELAN-A on the surface of the capsid. The therapeutic potential of bacteriophage vaccination alone or in combination with GET IL-12 was tested in vivo in a mouse malignant melanoma model. Response to treatment was further characterized by histological and immunohistochemical analyses of tumour tissue. No negative side effects were observed during treatment in mice. Engineered bacteriophage therapy significantly delayed tumour growth. GET IL-12 contributed to the therapeutic effect of engineered bacteriophages and increased tumour growth delay. Both therapies had a synergistic effect and led to complete responses in 30% of cases. Histological and immunohistochemical analyses have shown that both bacteriophage monotherapy and, especially in combination with GET IL-12, activate the immune system and increase the proportion of necrosis and the infiltration of macrophages, CD4 + and CD8 + T lymphocytes in tumours. For the first time, a cocktail of three engineered M13 bacteriophages displaying different melanoma-associated antigens with intratumoral IL-12 gene electrotransfer were applied, demonstrating a synergistic therapeutic effect in a highly aggressive melanoma model. Nanotechnological approaches, such as the use of genetically engineered bacteriophages, offer promising new avenues for the development of anti-tumour vaccines.Vir: Scientific reports [Elektronski vir]. - ISSN 2045-2322 (Vol. 15, [article no.] 18786, 2025, str. 1-12)Vrsta gradiva - e-članek ; neleposlovje za odrasleLeto - 2025Jezik - angleškiCOBISS.SI-ID - 239378435
Avtor
Brišar, Nuša |
Šuster, Katja |
Kranjc Brezar, Simona |
Cör, Andrej
Teme
immunotherapy |
bacteriophages |
bacteriophage display technology |
bacteriophage vaccine |
interleukin |
gene electrotransfer |
malignant melanoma |
imunoterapija |
bakteriofagi |
tehnologija prikaza bakteriofagov |
cepivo na osnovi bakteriofagov |
interlevkin |
genska elektroporacija |
maligni melanomi
| Avtor | Brišar, Nuša ... |
| Naslov | A virus based vaccine combined with IL12 gene therapy eradicates aggressive melanoma [Elektronski vir] |
| Datum objave | 2025-05-29 |
| COBISS.SI-ID | 239378435 |
| Verzija objave v repozitoriju | Založnikova različica |
| Licenca objave v repozitoriju | Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna |
| Embargo | Ni določeno |
Projekti in financerji, navedeni v objavi
| Naziv | Akronim | Številka projekta | Financer |
|---|---|---|---|
| Razvoj in ovrednotenje novih terapij za zdravljenje malignih tumorjev | P3-0003-2015 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
Datoteke, ki spadajo k objavi
| Povezava |
|---|
|
|
|
|
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
| Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
|---|---|---|---|---|---|---|---|---|
| JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP | |
Faktor vpliva
Baze podatkov, v katerih je revija indeksirana
| Ime baze podatkov | Področje | Leto |
|---|
| Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
|---|---|
| Brišar, Nuša | 54835 |
| Šuster, Katja | 35429 |
| Kranjc Brezar, Simona | 19058 |
| Cör, Andrej | 11308 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
| Mesto prevzema | Status gradiva | Rezervacija |
|---|
Prosimo, počakajte trenutek.